Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2019-06-18
2020-01-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Comparing the P200TE and the P200TxE in Glaucoma Patients
NCT03912584
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
NCT02921568
Navigated OCT Imaging With the P200TxE
NCT04003831
Retinal Investigation Using Optos OCT Device
NCT06846151
Performance of Long-wavelength Autofluorescence Imaging
NCT03592017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultra widefield image capture
P200TxE
The P200TxE ophthalmoscope provides widefield scanning laser ophthalmascope (SLO) fundus imaging.
P200DTx
The P200DTx ophthalmoscope provides widefield scanning laser ophthalmascope (SLO) fundus imaging.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
P200TxE
The P200TxE ophthalmoscope provides widefield scanning laser ophthalmascope (SLO) fundus imaging.
P200DTx
The P200DTx ophthalmoscope provides widefield scanning laser ophthalmascope (SLO) fundus imaging.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects who can follow the instructions by the clinical staff at the clinical site,
3. Subjects who agree to participate in the study;
4. Subjects diagnosed with retinal pathology. Example of pathologies may include but are not limited to Age-related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Macular Hole, Epiretinal Membrane, Central Serous Retinopathy, and others as confirmed by the investigator;
Exclusion Criteria
2. Subjects with ocular media not sufficiently clear to obtain acceptable images;
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optos, PLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Center Ophthalmology Associates
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPT1035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.